Clinical Trial: A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07868861) titled 'A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults' on Sept. 20.

Brief Summary: A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Chemotherapy-Induced Nausea and Vomiting (CINV) Radiotherapy-induced Nausea and Vomiting (RINV) Postoperative Nausea and Vomiting

Intervention: DRUG: NS003 Ondansetron HCl microspheres powder for nasal application

using nasal device (test)

DRUG: Ondansetron Solution for IV infusion 8mg

Available mark...